– Interview with Rainer Fuchs, Ph.D., Vice President and Executive Director of the Biogen Idec Innovation Incubator (bi3)

Previous articleMutation Identified that Is Associated with Peripheral Neuropathy
Next articleResearchers Ascertain Genes that Can Arrest Development of Regulatory T Cells